Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 141.8 SEK 0.07% Market Closed
Market Cap: 11.4B SEK

Wall Street
Price Targets

BIOT Price Targets Summary
Biotage AB

Wall Street analysts forecast BIOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOT is 146.88 SEK with a low forecast of 144.43 SEK and a high forecast of 152.25 SEK.

Lowest
Price Target
144.43 SEK
2% Upside
Average
Price Target
146.88 SEK
4% Upside
Highest
Price Target
152.25 SEK
7% Upside
Biotage AB Competitors:
Price Targets
DIM
Sartorius Stedim Biotech SA
28% Upside
1521
Frontage Holdings Corp
4% Downside
688315
Novogene Co Ltd
7% Upside
A
Agilent Technologies Inc
28% Upside
DXRX
Diaceutics PLC
48% Upside
LONN
Lonza Group AG
16% Upside
EVT
Evotec SE
84% Upside
BICO
BICO Group AB
74% Upside

Revenue
Forecast

Revenue Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's revenue is 15%. The projected CAGR for the next 3 years is 7%.

15%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's operating income is 19%. The projected CAGR for the next 3 years is 16%.

19%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's net income is 15%. The projected CAGR for the next 3 years is 17%.

15%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOT's stock price target?
Price Target
146.88 SEK

According to Wall Street analysts, the average 1-year price target for BIOT is 146.88 SEK with a low forecast of 144.43 SEK and a high forecast of 152.25 SEK.

What is Biotage AB's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Biotage AB's revenue is 15%. The projected CAGR for the next 3 years is 7%.

What is Biotage AB's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Biotage AB's operating income is 19%. The projected CAGR for the next 3 years is 16%.

What is Biotage AB's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Biotage AB's net income is 15%. The projected CAGR for the next 3 years is 17%.

Back to Top